Health Canada endorsed important safety information on BiCNU® (carmustine for injection, USP), 100 mg/vial

Bristol-Myers Squibb Canada has initiated a voluntary recall of certain BiCNU® (carmustine for injection USP) 100mg/vial lots. This recall is being conducted as a precautionary measure due to the discovery of an overfilled vial of carmustine following routine stability testing for a specific lot of BiCNU® which was not distributed in Canada. Read the entire notice here.